#
Dr. George McDonald

Liver Complications Following Antibody-Drug Conjugate Therapy

The advent of antibody-drug conjugates (ADC), designed to deliver a toxic moiety into tumor cells, has altered the approach to many cancers, particularly hematologic malignancies. However, unexpected toxicity has been seen after ADC therapies.

Read More
#
Dr. Neelendu Dey

Probiotics’ Effects on the Microbiome Vary Widely

Experiments in mice and people find that probiotic supplements don’t consistently change the composition of the gut microbiome, and may have adverse effects after antibiotics.

Read More
#
Continuing Medical Education

Save the Date! State-of-the-Art in Gastroenterology & Hepatology, Saturday, January 26th

This full-day continuing medical education course discusses the latest advances in research and state-of-the-art clinical practices in the fields of gastroenterology and hepatology.

Learn More
#
Dr. Will DePaolo

The Gut Microbiome and Brain Health

Shifts in the composition or function of the microbiome have been implicated in IBD, autism, and blood cancers. Researchers are now discovering that a disrupted microbiome, in certain contexts, may contribute to Alzheimer’s disease and related conditions that cause dementia.

Read More
#
Dr. George Ioannou

Estimating Risk of HCC Post HCV Antiviral Treatment

Most patients with hepatitis C virus have been treated or will be treated with direct-acting antivirals. It is important that we can model the risk of hepatocellular carcinoma in these patients.

Read More